Abpro Holdings, Inc.
ABPWW- Exchange
- OTC
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001893219
No open-market purchases or sales by Abpro Holdings, Inc. insiders were filed in the last 90 days; no institution reported holding it in 13F filings for Q2 2026; no superinvestor holds it.
Other share classesABPO
13F holders, Q1 2025
Institutional positions in Abpro Holdings, Inc. as of Mar 31, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 27
- −2 vs. Q4 2024
- Shares held
- 7.51M
- −499.9K (−6.2%) vs. Q4 2024
- Total value
- $243.4K
- −$360.0K (−59.7%) vs. Q4 2024
- New holders
- 0
- 2 more added
- Sold out
- 2
- 5 more reduced
Compare with Q4 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ABPWW on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 4 | $1.11K |
| Q4 2025 | 28 | $135.8K |
| Q3 2025 | 27 | $211.3K |
| Q2 2025 | 29 | $197.8K |
| Q1 2025 | 27 | $243.4K |
| Q4 2024 | 29 | $603.4K |
| Q3 2024 | 0 | $0 |
| Q2 2024 | 0 | $0 |
| Q1 2024 | 0 | $0 |
| Q4 2023 | 0 | $0 |
| Q3 2023 | 0 | $0 |
| Q2 2023 | 0 | $0 |
| Q1 2023 | 0 | $0 |
| Q4 2022 | 0 | $0 |
| Q3 2022 | 0 | $0 |
| Q2 2022 | 0 | $0 |
| Q1 2022 | 0 | $0 |
| Q4 2021 | 0 | $0 |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q1 2025
Shares, value and share of portfolio for each institution holding Abpro Holdings, Inc.; share changes are against Q4 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Meteora Capital, LLC | 10,354 | $264 | 0.00% | −100−1.0% | Reduced |
| Rivernorth Capital Management, LLC | 24,999 | $637 | 0.00% | 00.0% | Unchanged |
| Omers Administration Corp | 25,000 | $695 | 0.00% | 00.0% | Unchanged |
| Sculptor Capital LP | 34,101 | $946 | 0.00% | 00.0% | Unchanged |
| Flow Traders U.S. LLC | 24,533 | $1.00K | 0.00% | +1,249+5.4% | Added |
| Yakira Capital Management, Inc. | 50,000 | $1.27K | 0.00% | 00.0% | Unchanged |
| Picton Mahoney Asset Management | 125,000 | $3.00K | 0.00% | 00.0% | Unchanged |
| LMR Partners LLP | 125,000 | $3.19K | 0.00% | 00.0% | Unchanged |
| Goldman Sachs Group Inc | 179,100 | $4.57K | 0.00% | 00.0% | Unchanged |
| Tenor Capital Management Co., L.P. | 200,000 | $5.10K | 0.00% | 00.0% | Unchanged |
| Verition Fund Management LLC | 225,000 | $5.74K | 0.00% | 00.0% | Unchanged |
| Barclays PLC | 250,000 | $6.38K | 0.00% | −120.0% | Reduced |
| Davidson Kempner Capital Management LP | 250,000 | $6.38K | 0.00% | 00.0% | Unchanged |
| Aristeia Capital LLC | 273,125 | $7.58K | 0.00% | −5,334−1.9% | Reduced |
| Clear Street LLC | 327,185 | $8.34K | 0.00% | +1000.0% | Added |
| Sandia Investment Management LP | 358,427 | $9.14K | 0.03% | 00.0% | Unchanged |
| Cantor Fitzgerald, L. P. | 375,000 | $9.56K | 0.00% | 00.0% | Unchanged |
| Polar Asset Management Partners Inc. | 378,328 | $10.5K | 0.00% | 00.0% | Unchanged |
| D. E. Shaw & Co., Inc. | 375,000 | $11.3K | 0.00% | 00.0% | Unchanged |
| Wolverine Asset Management LLC | 472,132 | $12.0K | 0.00% | −2,214−0.5% | Reduced |
| Linden Advisors LP | 499,999 | $13.8K | 0.00% | 00.0% | Unchanged |
| CNH Partners LLC | 631,725 | $16.1K | 0.00% | −10,164−1.6% | Reduced |
| MMCAP International Inc. SPC | 675,000 | $17.2K | 0.00% | 00.0% | Unchanged |
| Highbridge Capital Management LLC | – | $17.3K | 0.00% | – | – |
| Calamos Advisors LLC | 625,000 | $17.3K | 0.00% | 00.0% | Unchanged |
| JPMorgan Chase & Co | – | $26.3K | 0.00% | – | – |
| Saba Capital Management, L.P. | 997,048 | $27.7K | 0.00% | 00.0% | Unchanged |
| Diametric Capital, LP | 0 | $0 | 0.00% | −358,427−100.0% | Sold out |
| Shaolin Capital Management LLC | 0 | $0 | 0.00% | −125,000−100.0% | Sold out |